Adicet Bio Inc. – Filings and Transcripts

NASDAQ: ACET
Share price (11/9/26): $2.99
Market cap (11/9/26): $28.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 12/31/25 FY 2025 – amended

ended 03/31/26 Q1

ended 12/31/25 FY 2025

Prospectuses and Registrations Filter

Amendment to registration of securities for employees

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Franklin Templeton Inc Com

Zedek Daniel Clayton

Ra Capital Management, L.P.

Klickstein Lloyd

News Filter

Reports Third Quarter 2026 Financial Results and Provides Business Updates

Announces Positive Safety and Efficacy Data From Prula-Cel (Formerly ADI-001) Study in Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis

Investor Presentation

Announces Completion of Last Patient Visit for Planned Analysis of Prula-Cel (Formerly ADI-001) Study in Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update

Reports Second Quarter 2026 Financial Results and Provides Business Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission